 |
Previous Article | Next Article 
The Journal of Neuroscience, May 15, 2002, 22(10):3963-3968
-Amyloid-Induced Synthesis of the Ganglioside Gd3 Is a
Requisite for Cell Cycle Reactivation and Apoptosis in Neurons
Agata
Copani1,
Daniela
Melchiorri3,
Andrea
Caricasole3,
Francesca
Martini4,
Patrizio
Sale4,
Roberto
Carnevale4,
Roberto
Gradini4,
Maria Angela
Sortino2,
Luisa
Lenti4,
Ruggero
De
Maria5, and
Ferdinando
Nicoletti3, 6
Departments of 1 Pharmaceutical Sciences and
2 Experimental and Clinical Pharmacology, University of
Catania, 95125 Catania, Italy, Departments of
3 Human Physiology and Pharmacology and
4 Experimental Medicine and Pathology, University of Rome
"La Sapienza," 00185 Rome, Italy, 5 Laboratory
of Hematology and Oncology, Istituto Superiore di Sanità, 00185 Rome, Italy, and 6 I.N.M. Neuromed, 86077 Pozzilli, Italy
We have shown that cortical neurons challenged with toxic
concentrations of -amyloid peptide ( AP) enter the S phase of the cell cycle before apoptotic death. Searching for a signaling molecule that lies at the border between cell proliferation and apoptotic death,
we focused on the disialoganglioside GD3. Exposure of rat cultured
cortical neurons to 25 µM AP(25-35) induced a
substantial increase in the intracellular levels of GD3 after 4 hr, a
time that precedes neuronal entry into S phase. GD3 levels decreased but still remained higher than in the control cultures after 16 hr of
exposure to AP(25-35). Confocal microscopy analysis showed that the
GD3 synthesized in response to AP colocalized with nuclear chromatin. The increase in GD3 was associated with a reduction of
sphingomyelin (the main source of the ganglioside precursor ceramide) and with the induction of -2,8-sialyltransferase
(GD3 synthase), the enzyme that forms GD3 from the monosialoganglioside GM3. A causal relationship between GD3, cell-cycle activation, and
apoptosis was demonstrated by treating the cultures with antisense oligonucleotides directed against GD3 synthase. This treatment, which
reduced AP(25-35)-stimulated GD3 formation by ~50%, abolished the neuronal entry into the S phase and was protective against AP(25-35)-induced apoptosis.
Key words:
Alzheimer's disease; -amyloid; cell cycle; ganglioside GD3; apoptosis; neurodegeneration
Copyright © 2002 Society for Neuroscience 0270-6474/02/22103963-06$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
R. W. Ledeen and G. Wu
Thematic Review Series: Sphingolipids. Nuclear sphingolipids: metabolism and signaling
J. Lipid Res.,
June 1, 2008;
49(6):
1176 - 1186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Amit, Y. Avramovich-Tirosh, M. B. H. Youdim, and S. Mandel
Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators
FASEB J,
May 1, 2008;
22(5):
1296 - 1305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kang, S.-K. Kang, Y.-C. Lee, H.-J. Choi, Y.-S. Lee, S.-Y. Cho, Y.-S. Kim, J.-H. Ko, and C.-H. Kim
Transcriptional regulation of the human GD3 synthase gene expression in Fas-induced Jurkat T cells: a critical role of transcription factor NF-{kappa}B in regulated expression
Glycobiology,
May 1, 2006;
16(5):
375 - 389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Lovat, F. Di Sano, M. Corazzari, B. Fazi, R. P. Donnorso, A. D. J. Pearson, A. G. Hall, C. P. F. Redfern, and M. Piacentini
Gangliosides Link the Acidic Sphingomyelinase-Mediated Induction of Ceramide to 12-Lipoxygenase-Dependent Apoptosis of Neuroblastoma in Response to Fenretinide
J Natl Cancer Inst,
September 1, 2004;
96(17):
1288 - 1299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Ledeen and G. Wu
Nuclear lipids: key signaling effectors in the nervous system and other tissues
J. Lipid Res.,
January 1, 2004;
45(1):
1 - 8.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Satake, H. Y. Chen, and A. Varki
Genes Modulated by Expression of GD3 Synthase in Chinese Hamster Ovary Cells. EVIDENCE THAT THE Tis21 GENE IS INVOLVED IN THE INDUCTION OF GD3 9-O-ACETYLATION
J. Biol. Chem.,
February 28, 2003;
278(10):
7942 - 7948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Y. Chen and A. Varki
O-acetylation of GD3: An Enigmatic Modification Regulating Apoptosis?
J. Exp. Med.,
December 16, 2002;
196(12):
1529 - 1533.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Garcia-Ruiz, A. Colell, A. Morales, M. Calvo, C. Enrich, and J. C. Fernandez-Checa
Trafficking of Ganglioside GD3 to Mitochondria by Tumor Necrosis Factor-alpha
J. Biol. Chem.,
September 20, 2002;
277(39):
36443 - 36448.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|